Skip to main navigation Skip to search Skip to main content

What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients?

  • Karan Raja
  • , Antoinette Acbo
  • , Humberto R. Jimenez
  • , David Silverman
  • , Austin Golia
  • , Alyssa Joy Ford
  • , Priya Nori

Research output: Contribution to journalReview articlepeer-review

Abstract

Pharmacy Benefit Managers (PBMs) are contracted by health plans, employers, and government programs to manage pharmacy and prescription drug benefits. They maintain drug formularies, process and pay pharmacy claims, establish and manage pharmacy networks, and negotiate prices with manufacturers and pharmacies. Despite PBMs’ role in cost management, their lack of transparency and complex administrative processes can delay treatment and increase out-of-pocket costs, affecting vulnerable populations like those in pharmacy deserts. These factors influence healthcare delivery for persons living with human immunodeficiency virus, Hepatitis C Virus, and other conditions. Herein, we describe PBM practices and their impacts on infectious diseases patients and highlight mitigation strategies to facilitate timely and equitable medication access.

Original languageEnglish (US)
Article numbere18
JournalAntimicrobial Stewardship and Healthcare Epidemiology
Volume6
Issue number1
DOIs
StatePublished - Jan 13 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients?'. Together they form a unique fingerprint.

Cite this